Trial intelligence / Profile preview

Levamlodipine/Atorvastatin Combination in Hypertension with Dyslipidemia

CTR20150372Phase 2Active

Sponsor
CSPC Ouyi Pharmaceutical
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of levamlodipine + atorvastatin in hypertension (HTN), dyslipidemia, sponsored by CSPC Ouyi Pharmaceutical. Started Jun 2015; status: active.

02

Drugs

levamlodipine + atorvastatin
03

Conditions

hypertension (HTN)dyslipidemia

Beyond the preview

Go deeper on CTR20150372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call